Jain Global LLC Tg Therapeutics, Inc. Transaction History
Jain Global LLC
- $7.88 Billion
- Q1 2025
A detailed history of Jain Global LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Jain Global LLC holds 11,884 shares of TGTX stock, worth $424,853. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,884
Previous 7,672
54.9%
Holding current value
$424,853
Previous $231 Million
99.8%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$558 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$407 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$266 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$117 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$102 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.19B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...